Last €10.66 EUR
Change Today -0.14 / -1.30%
Volume 14.4K
ALCLS On Other Exchanges
Symbol
Exchange
EN Paris
Frankfurt
OTC US
As of 11:35 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin Bitsch M.D.

Former Independent Director and Member of Compensation Committee, Cellectis
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 3 different industries.

See Board Relationships
69--

Background*

Mr. Martin Bitsch, MD serves as an Investment Manager of BI Biomedical Venture III BI BioMedical Venture IV and BankInvest BioMedical Venture. Dr. Bitsch is a co-founder of Genmab A/S (Denmark). After ten years of general practice, Dr. Bitsch joined the pharmaceutical industry by becoming Director of Clinical Investigations with Roche for Scandinavia and then for America and Europe and finally, the world. In 1996, he joined the IBAH group, firstly as director of the ...

Read Full Background

Corporate Headquarters*

8 rue de la Croix Jarry
Paris, Ile-de-France 75013

France

Phone: 33 1 81 69 16 00
Fax: --

Board Members Memberships*

Former Director
Former Independent Director and Member of Compensation Committee
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALCLS:FP €10.66 EUR -0.14

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$8.5M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
--
Robert J. Palay MBA, J.D.Founder, Chairman of the Board and Chief Executive Officer
Cellular Dynamics International, Inc.
$475.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLECTIS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.